A detailed history of Concourse Financial Group Securities, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 1,242 shares of DGX stock, worth $170,265. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,242
Previous 1,306 4.9%
Holding current value
$170,265
Previous $178,000 4.49%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$137.09 - $137.09 $8,773 - $8,773
-64 Reduced 4.9%
1,242 $170,000
Q2 2024

Jul 23, 2024

SELL
$125.91 - $144.34 $1,888 - $2,165
-15 Reduced 1.14%
1,306 $178,000
Q1 2024

Apr 30, 2024

SELL
$123.78 - $142.11 $24,756 - $28,422
-200 Reduced 13.15%
1,321 $175,000
Q4 2023

Feb 07, 2024

SELL
$120.62 - $141.12 $482 - $564
-4 Reduced 0.26%
1,521 $209,000
Q3 2023

Oct 25, 2023

BUY
$121.86 - $144.92 $5,971 - $7,101
49 Added 3.32%
1,525 $185,000
Q2 2023

Aug 10, 2023

BUY
$130.56 - $146.84 $1,175 - $1,321
9 Added 0.61%
1,476 $207,000
Q1 2023

May 15, 2023

BUY
$131.53 - $155.76 $1,578 - $1,869
12 Added 0.82%
1,467 $207,000
Q4 2022

Jan 30, 2023

SELL
$123.31 - $157.26 $3,575 - $4,560
-29 Reduced 1.95%
1,455 $0
Q3 2022

Nov 15, 2022

SELL
$121.77 - $141.1 $4,870 - $5,644
-40 Reduced 2.62%
1,484 $182,000
Q2 2022

Aug 09, 2022

BUY
$127.07 - $145.39 $15,883 - $18,173
125 Added 8.93%
1,524 $203,000
Q1 2022

May 09, 2022

SELL
$129.09 - $164.35 $11,359 - $14,462
-88 Reduced 5.92%
1,399 $192,000
Q4 2021

Feb 07, 2022

SELL
$140.36 - $173.01 $2,105 - $2,595
-15 Reduced 1.0%
1,487 $257,000
Q3 2021

Nov 09, 2021

BUY
$132.95 - $158.0 $26,988 - $32,074
203 Added 15.63%
1,502 $218,000
Q2 2021

Aug 13, 2021

SELL
$126.66 - $141.48 $74,856 - $83,614
-591 Reduced 31.27%
1,299 $171,000
Q1 2021

May 13, 2021

SELL
$114.63 - $133.34 $51,124 - $59,469
-446 Reduced 19.09%
1,890 $243,000
Q4 2020

Feb 02, 2021

SELL
$112.7 - $128.05 $54,997 - $62,488
-488 Reduced 17.28%
2,336 $278,000
Q3 2020

Nov 13, 2020

BUY
$107.05 - $130.01 $32,115 - $39,003
300 Added 11.89%
2,824 $323,000
Q2 2020

Aug 13, 2020

BUY
$73.34 - $122.61 $50,164 - $83,865
684 Added 37.17%
2,524 $288,000
Q1 2020

May 13, 2020

BUY
$75.14 - $115.68 $14,351 - $22,094
191 Added 11.58%
1,840 $148,000
Q4 2019

Feb 14, 2020

BUY
$100.29 - $107.99 $24,972 - $26,889
249 Added 17.79%
1,649 $176,000
Q3 2019

Nov 13, 2019

SELL
$97.85 - $107.42 $4,403 - $4,833
-45 Reduced 3.11%
1,400 $150,000
Q2 2019

Aug 13, 2019

BUY
$85.18 - $101.94 $5,451 - $6,524
64 Added 4.63%
1,445 $147,000
Q1 2019

May 15, 2019

SELL
$80.68 - $89.92 $2,420 - $2,697
-30 Reduced 2.13%
1,381 $124,000
Q4 2018

Feb 14, 2019

BUY
$79.75 - $108.38 $28,151 - $38,258
353 Added 33.36%
1,411 $117,000
Q3 2018

Nov 13, 2018

BUY
$105.42 - $114.99 $111,534 - $121,659
1,058 New
1,058 $114,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.